Personal Economics
  • New Cancer Drugs: Affordable by the 1 Percent?

    By Merrill Goozner, The Fiscal Times

    ontrolling the increasing cost of cancer care is emerging as the number one issue for government health care programs like Medicare and Medicaid as well as private insurers. The cost of new therapies...

  • Medicare Reforms from House GOP

    By RICHARD LAWDER, Reuters

    Republicans in the House of Representatives will put forward a budget plan this year that will seek substantial reforms to health benefits for the elderly and make aggressive strides toward reducing...

  • Too Cheap with Your Valued Staff? Know the Risks

    By Knowledger@Wharton

    As economic malaise bleeds into another New Year, employers are making hard-nosed decisions about benefits and compensation. That means for many in the nation's workforce, compensation remains flat,...

  • The Surprising Embezzler Sitting in Your Office

    By COURTNEY RUBIN, Inc.com

    A new study reports that loss due to embezzlement is down slightly this year – but it also fingers some unlikely suspects.

  • Two Financial Scenarios from Gloom to Zoom

    By Suzanne McGee, The Fiscal Times

    Do you feel lucky this year? If so, you might want to bet on the optimistic side of the theoretical coin toss that the strategy team at BlackRock Investment Institute proposed in their investment...